In contrast, Troseid et al. observed a decrease in MCP-1 levels 12 weeks after endurance and strength training in subjects with metabolic syndrome [65], but did not report any intermediate changes before 12 weeks. This evidence concerns the gene CCL2 and metabolic syndrome.